Dear Doctor Letter (Rote-Hand-Brief) on Eligard® (leuprorelin acetate): medication errors due to overtightening of the safety needle
2017.12.14
Active substance: leuprorelin acetate
The company Astellas is circulating information on medication errors reported in connection with leakage of the medicinal product from the syringe.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN